• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本烟雾病的流行病学特征。

Epidemiological features of moyamoya disease in Japan.

作者信息

Hoshino Haruhiko, Izawa Yoshikane, Suzuki Norihiro

机构信息

Department of Neurology and Stroke Center, Tokyo Saiseikai Central Hospital, Tokyo, Japan.

出版信息

Neurol Med Chir (Tokyo). 2012;52(5):295-8. doi: 10.2176/nmc.52.295.

DOI:10.2176/nmc.52.295
PMID:22688065
Abstract

To clarify the clinical features of moyamoya disease in Japan, 941 patients with definite moyamoya disease were analyzed from the databases constructed by the Research Committee on Moyamoya Disease, established by the Ministry of Health, Labour and Welfare. Moyamoya disease occurs much more frequently among women than men, with a female-to-male ratio of 1.98. A family history of the disease was observed in 14.9%. The age at onset was characterized by two peaks: one at 5-9 years and another lower peak at around 40 years. Initial clinical features were transient ischemic attack in 46%, infarction in 20%, hemorrhage in 21%, headache in 6%, and epilepsy in 4%. The distribution of the age at onset showed one peak at around 40 years in patients with hemorrhage but two peaks in patients with ischemia.

摘要

为明确日本烟雾病的临床特征,我们对厚生劳动省设立的烟雾病研究委员会构建的数据库中的941例确诊烟雾病患者进行了分析。烟雾病在女性中的发病率远高于男性,女性与男性的比例为1.98。14.9%的患者有该病家族史。发病年龄有两个高峰:一个在5-9岁,另一个较低的高峰在40岁左右。初始临床特征为短暂性脑缺血发作占46%,梗死占20%,出血占21%,头痛占6%,癫痫占4%。发病年龄分布在出血患者中约40岁有一个高峰,而在缺血患者中有两个高峰。

相似文献

1
Epidemiological features of moyamoya disease in Japan.日本烟雾病的流行病学特征。
Neurol Med Chir (Tokyo). 2012;52(5):295-8. doi: 10.2176/nmc.52.295.
2
Nationwide survey on quasi-moyamoya disease in Japan.日本全国性烟雾病样疾病调查。
Acta Neurochir (Wien). 2014 May;156(5):935-40. doi: 10.1007/s00701-014-2013-0. Epub 2014 Feb 6.
3
Clinical features of probable moyamoya disease in Japan.日本疑似烟雾病的临床特征。
Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2:S173-7. doi: 10.1016/s0303-8467(97)00053-x.
4
A clinical comparison of definite moyamoya disease between South Korea and Japan.韩国和日本确诊烟雾病的临床比较。
Stroke. 1997 Dec;28(12):2513-7. doi: 10.1161/01.str.28.12.2513.
5
Posterior circulation and high prevalence of ischemic stroke among young pediatric patients with Moyamoya disease: evidence of angiography-based differences by age at diagnosis.后循环和高患病率缺血性卒中在年轻儿科患者与烟雾病:基于血管造影的证据差异按年龄诊断。
AJNR Am J Neuroradiol. 2011 Jan;32(1):192-8. doi: 10.3174/ajnr.A2216. Epub 2010 Aug 26.
6
Epidemiological survey of moyamoya disease in Korea.韩国烟雾病的流行病学调查。
Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2:S6-10. doi: 10.1016/s0303-8467(97)00032-2.
7
Epidemiological and clinical features of moyamoya disease in the USA.美国烟雾病的流行病学和临床特征。
Neuroepidemiology. 2013;40(4):282-7. doi: 10.1159/000345957. Epub 2013 Feb 23.
8
Novel epidemiological features of moyamoya disease.烟雾病的新型流行病学特征。
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):900-4. doi: 10.1136/jnnp.2007.130666. Epub 2007 Dec 12.
9
Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study.台湾地区烟雾病的流行病学:一项基于全国人口的研究。
Stroke. 2014 May;45(5):1258-63. doi: 10.1161/STROKEAHA.113.004160. Epub 2014 Mar 27.
10
Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.美国烟雾病症状表现的差异:一项全国性全支付方分析。
J Clin Neurosci. 2021 May;87:92-96. doi: 10.1016/j.jocn.2021.02.019. Epub 2021 Mar 20.

引用本文的文献

1
Moyamoya syndrome in a 6-year-old β-thalassemia major patient: A case report.一名6岁重型β地中海贫血患者的烟雾病综合征:病例报告
Radiol Case Rep. 2025 May 29;20(8):4076-4081. doi: 10.1016/j.radcr.2025.04.129. eCollection 2025 Aug.
2
Deep learning model for automated diagnosis of moyamoya disease based on magnetic resonance angiography.基于磁共振血管造影的烟雾病自动诊断深度学习模型
EClinicalMedicine. 2024 Nov 5;77:102888. doi: 10.1016/j.eclinm.2024.102888. eCollection 2024 Nov.
3
Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease.
二十多岁缺血性烟雾病患者的临床特征和治疗结果。
Cerebrovasc Dis Extra. 2024;14(1):105-115. doi: 10.1159/000540769. Epub 2024 Aug 12.
4
Assessing donor-recipient arterial pressure dynamics in STA-MCA bypass for moyamoya disease.评估烟雾病颞浅动脉-大脑中动脉搭桥术中供体-受体动脉压动态变化
Chin Neurosurg J. 2024 May 12;10(1):15. doi: 10.1186/s41016-024-00367-2.
5
Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature.东南亚的 moyamoya 病:遗传和尸检数据、新病例、系统评价以及对文献中所有患者的荟萃分析。
J Neurol. 2024 Jun;271(6):3328-3339. doi: 10.1007/s00415-024-12228-0. Epub 2024 Mar 13.
6
Classification and treatment strategy for Moyamoya disease-related aneurysms.烟雾病相关动脉瘤的分类及治疗策略
Chin Neurosurg J. 2023 Dec 20;9(1):37. doi: 10.1186/s41016-023-00352-1.
7
Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing.通过 miRNA 测序的全面表达分析揭示了脑脊液中 moyamoya 病特异性细胞外囊泡衍生 microRNAs。
Acta Neurochir (Wien). 2023 Aug;165(8):2045-2055. doi: 10.1007/s00701-023-05579-6. Epub 2023 Apr 20.
8
Advances in the Diagnosis and Treatment of Pediatric Arterial Ischemic Stroke.小儿动脉缺血性脑卒中的诊治进展。
Neurotherapeutics. 2023 Apr;20(3):633-654. doi: 10.1007/s13311-023-01373-5. Epub 2023 Apr 18.
9
Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.NOS3 和 GUCY1A3 中的双等位基因变异是导致烟雾病的两个主要一氧化氮通路基因。
Hum Genomics. 2023 Mar 20;17(1):24. doi: 10.1186/s40246-023-00471-x.
10
The Pathogenetic Mechanism for Moyamoya Vasculopathy Including a Possible Trigger Effect of Increased Flow Velocity.烟雾病血管病变的发病机制,包括血流速度增加可能产生的触发效应。
JMA J. 2023 Jan 16;6(1):16-24. doi: 10.31662/jmaj.2022-0104. Epub 2022 Dec 19.